Skip to main content
Premium Trial:

Request an Annual Quote

Genome Pharmaceuticals Appoints Six to New Board of Directors


MUNICH--Genome Pharmaceuticals, a functional genomics company here, has announced a new six-member board of directors. Members include Juergen Drews, president of global research for Hoffmann-La Roche; Ansbert Gaedicke, managing director of Venture Asset Management; Hans Lehrach, director and scientific cofounder of the Max Planck Institute for Molecular Genetics; Helmut Schuehsler, managing partner of TVM Techno Venture Management; Wolfgang Stoiber, managing director of MPM Capital; Ernst-Ludwig Winnacker, director of the Gene Center Munich and president of the Deutsche Forschungsgemeinschaft.

The appointments coincided with a corporate reorganization which, according to Elmar Maier, vice-president of business development, "will provide us with new advantages in Germany, such as equity-based compensation and financing strategies. This will help us attract outstanding individuals to the company and rapidly expand our business." Genome Pharmaceuticals offers an integrated platform of automated high-throughput genomic technologies that includes gene expression analyses, protein interaction mapping, and bioinformatics tools. It plans to collaborate with pharmaceutical companies, offering a combination of three genomic databases.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.